IMMUNOGLOBULIN G SUBCLASS (IgG1/IgG2/IgG3/IgG4)
ANVISA Registration Number: 80254180417PHADIA DIAGNOSTICOS LTDAPHADIA ABRisk Class II
Device names
- Technical name
- IMMUNOGLOBULIN G SUBCLASS (IgG1/IgG2/IgG3/IgG4)
- Risk class
- Class II
PT: SUBCLASSE DE IMUNOGLOBULINA G (IgG1/IgG2/IgG3/IgG4)
Registration details
- Registration Number
- 80254180417
- Process Number
- 25351500131202257
- CNPJ
- 04930429000139
Company information
- Registration Holder
- PHADIA DIAGNOSTICOS LTDA
- Manufacturer
- PHADIA AB
- Manufacturing Country
- Sweden
PT: SUÉCIA
Dates and status
- Publication Date
- May 19, 2022
- Validity
- VIGENTE
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for IMMUNOGLOBULIN G SUBCLASS (IgG1/IgG2/IgG3/IgG4) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180417 and manufactured by PHADIA AB. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.